An institution in Japan launched the AI diagnostic technology developed by Alibaba Cloud for COVID-19 treatment 日本启用阿里云新冠肺炎AI诊断技术

2020-04-02 03:05:38 source: cztv.com


1.jpg


On March 31, Japan's medical science and technology institution JBC officially launched Alibaba Cloud AI diagnostic technology for COVID-19 and began to provide this service to Japanese hospitals to help doctors quickly screen for COVID-19 through CT images. The technology has been applied in nearly 170 Chinese hospitals, and CT diagnosis can be completed in 20 seconds with an accuracy rate of 96%.


JBC is a well-known medical science and technology institution in Japan and has long-term cooperation with Yamanashi University Medical College. Recently, the epidemic situation in Japan has become tense again. With the increasing confirmed cases in densely populated cities like Tokyo, the AI diagnostic technology for COVID-19 will help hospitals conduct more extensive screening of suspected cases.


JBC said that Japanese doctors could acquire this technology through a cloud-based deployment system. Doctors upload CT scanning images of suspected patients to obtain the analyzed auxiliary diagnosis results. "We pay tribute to the medical staff fighting in the frontline, and hopes that this technology can relieve their burden.”


Not long ago, Alibaba Cloud announced to offer AI diagnostic technology for free to hospitals around the world. With such technology, the CT diagnosis of suspected cases can be completed in 20 seconds with an accuracy rate of more than 96%. This technology was developed by Dharma Institute, and Ali Health provided scene technical support. Nearly 170 domestic hospitals including Wuhan Huoshenshan Hospital and Zhengzhou Qiboshan Hospital have applied this technology with a cumulative clinical diagnosis of more than 340,000 cases.


So far, together with Dharma Institute and Alibaba Health, Alibaba Cloud has provided technology and experience for dozens of countries to fight the epidemic. In an interview with Bloomberg, a French government official said they welcomed this technology and that "France will not refuse the research and diagnostic technology developed by Alibaba."


3月31日消息,日本医疗科技机构JBC正式上线阿里云新冠肺炎AI诊断技术,开始向日本医院提供这一服务,帮助医生通过CT影像快速进行新冠肺炎筛查。该技术已在中国近170家医院上线,20秒即可完成一次CT诊断,准确率达96%。


JBC是日本知名的医疗科技机构,与日本山梨大学医学院具有长期合作。近日,日本疫情再度紧张,随着东京等人口密集城市的病例增加,新冠肺炎AI诊断技术将帮助医院有能力进行更广泛的疑似病例筛查。


JBC介绍,日本医生可以通过基于云端部署的系统,获得新冠肺炎AI辅助技术,医生上传疑似患者的CT扫描图片,即可得到分析后的辅助诊断结果,“向奋战在一线的医疗工作者致敬,希望这一技术能够为他们分担繁重的工作。”


不久前,阿里云宣布向全球医院免费开放新冠肺炎AI诊断技术,20秒即可完成一次疑似病例的CT诊断,准确率达96%以上。这一技术由达摩院研发,阿里健康提供场景技术支持。武汉火神山医院、郑州岐伯山医院等近170家国内医院已经上线应用,累积临床诊断病例超过34万。


截止目前,阿里云联合达摩院、阿里健康正在为全球数十个国家抗疫提供技术和经验。法国政府人士在接受彭博社采访时表示,欢迎这一技术落地,“阿里巴巴贡献出研究和诊断技术,法国不会拒绝这样的帮助。”




(Executive Editor: Ye Ke)

read more

11841791 An institution in Japan launched the AI diagnostic technology developed by Alibaba Cloud for COVID-19 treatment 日本启用阿里云新冠肺炎AI诊断技术 public html

1.jpg


On March 31, Japan's medical science and technology institution JBC officially launched Alibaba Cloud AI diagnostic technology for COVID-19 and began to provide this service to Japanese hospitals to help doctors quickly screen for COVID-19 through CT images. The technology has been applied in nearly 170 Chinese hospitals, and CT diagnosis can be completed in 20 seconds with an accuracy rate of 96%.


JBC is a well-known medical science and technology institution in Japan and has long-term cooperation with Yamanashi University Medical College. Recently, the epidemic situation in Japan has become tense again. With the increasing confirmed cases in densely populated cities like Tokyo, the AI diagnostic technology for COVID-19 will help hospitals conduct more extensive screening of suspected cases.


JBC said that Japanese doctors could acquire this technology through a cloud-based deployment system. Doctors upload CT scanning images of suspected patients to obtain the analyzed auxiliary diagnosis results. "We pay tribute to the medical staff fighting in the frontline, and hopes that this technology can relieve their burden.”


Not long ago, Alibaba Cloud announced to offer AI diagnostic technology for free to hospitals around the world. With such technology, the CT diagnosis of suspected cases can be completed in 20 seconds with an accuracy rate of more than 96%. This technology was developed by Dharma Institute, and Ali Health provided scene technical support. Nearly 170 domestic hospitals including Wuhan Huoshenshan Hospital and Zhengzhou Qiboshan Hospital have applied this technology with a cumulative clinical diagnosis of more than 340,000 cases.


So far, together with Dharma Institute and Alibaba Health, Alibaba Cloud has provided technology and experience for dozens of countries to fight the epidemic. In an interview with Bloomberg, a French government official said they welcomed this technology and that "France will not refuse the research and diagnostic technology developed by Alibaba."


3月31日消息,日本医疗科技机构JBC正式上线阿里云新冠肺炎AI诊断技术,开始向日本医院提供这一服务,帮助医生通过CT影像快速进行新冠肺炎筛查。该技术已在中国近170家医院上线,20秒即可完成一次CT诊断,准确率达96%。


JBC是日本知名的医疗科技机构,与日本山梨大学医学院具有长期合作。近日,日本疫情再度紧张,随着东京等人口密集城市的病例增加,新冠肺炎AI诊断技术将帮助医院有能力进行更广泛的疑似病例筛查。


JBC介绍,日本医生可以通过基于云端部署的系统,获得新冠肺炎AI辅助技术,医生上传疑似患者的CT扫描图片,即可得到分析后的辅助诊断结果,“向奋战在一线的医疗工作者致敬,希望这一技术能够为他们分担繁重的工作。”


不久前,阿里云宣布向全球医院免费开放新冠肺炎AI诊断技术,20秒即可完成一次疑似病例的CT诊断,准确率达96%以上。这一技术由达摩院研发,阿里健康提供场景技术支持。武汉火神山医院、郑州岐伯山医院等近170家国内医院已经上线应用,累积临床诊断病例超过34万。


截止目前,阿里云联合达摩院、阿里健康正在为全球数十个国家抗疫提供技术和经验。法国政府人士在接受彭博社采访时表示,欢迎这一技术落地,“阿里巴巴贡献出研究和诊断技术,法国不会拒绝这样的帮助。”




(Executive Editor: Ye Ke)

]]>
technology;hospitals;Alibaba;medical;Cloud;doctors;Japan;screen;completed;accuracy